GB1477545A - Drug delivery devices - Google Patents

Drug delivery devices

Info

Publication number
GB1477545A
GB1477545A GB2165075A GB2165075A GB1477545A GB 1477545 A GB1477545 A GB 1477545A GB 2165075 A GB2165075 A GB 2165075A GB 2165075 A GB2165075 A GB 2165075A GB 1477545 A GB1477545 A GB 1477545A
Authority
GB
United Kingdom
Prior art keywords
drug delivery
matrix
delivery devices
delivery device
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2165075A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GB1477545A publication Critical patent/GB1477545A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB2165075A 1974-06-07 1975-05-20 Drug delivery devices Expired GB1477545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US477297A US3923939A (en) 1974-06-07 1974-06-07 Process for improving release kinetics of a monolithic drug delivery device

Publications (1)

Publication Number Publication Date
GB1477545A true GB1477545A (en) 1977-06-22

Family

ID=23895337

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2165075A Expired GB1477545A (en) 1974-06-07 1975-05-20 Drug delivery devices

Country Status (10)

Country Link
US (1) US3923939A (enrdf_load_stackoverflow)
JP (1) JPS6043327B2 (enrdf_load_stackoverflow)
CA (1) CA1047403A (enrdf_load_stackoverflow)
CH (1) CH611160A5 (enrdf_load_stackoverflow)
DE (1) DE2525061C2 (enrdf_load_stackoverflow)
FR (1) FR2273515A1 (enrdf_load_stackoverflow)
GB (1) GB1477545A (enrdf_load_stackoverflow)
IT (1) IT1036192B (enrdf_load_stackoverflow)
MX (1) MX3007E (enrdf_load_stackoverflow)
SE (1) SE405803B (enrdf_load_stackoverflow)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US4145408A (en) * 1976-08-16 1979-03-20 The Procter & Gamble Company Controlled release article
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
US4190642A (en) * 1978-04-17 1980-02-26 Alza Corporation Ocular therapeutic system for dispensing a medication formulation
US4156604A (en) * 1978-09-15 1979-05-29 Minnesota Mining And Manufacturing Company Controlled delivery of corrosion inhibitors for silver recovery cartridges
US4333850A (en) * 1979-06-15 1982-06-08 Borg-Warner Corporation Filled polymer composition for automatic addition of a corrosion inhibitor to a coolant system
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPS5931701A (ja) * 1982-08-16 1984-02-20 Nitto Electric Ind Co Ltd 液状活性物質含有膜及びその製造方法
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
GB8331546D0 (en) * 1983-11-25 1984-01-04 Exxon Research Engineering Co Polymeric compositions
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629620A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4874366A (en) * 1984-12-03 1989-10-17 Baxter Internatiional Inc. Housing enabling passive mixing of a beneficial agent with a diluent
WO1986003416A1 (en) * 1984-12-03 1986-06-19 Baxter Travenol Laboratories, Inc. Drug delivery apparatus preventing local and systemic toxicity
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
US4917895A (en) * 1987-11-02 1990-04-17 Alza Corporation Transdermal drug delivery device
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US5165944A (en) * 1989-04-19 1992-11-24 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US4978537A (en) * 1989-04-19 1990-12-18 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5108762A (en) * 1989-04-19 1992-04-28 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5198251A (en) * 1989-04-19 1993-03-30 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US5229148A (en) * 1989-04-19 1993-07-20 Wm. Wrigley Jr. Company Method of combining active ingredients with polyvinyl acetates
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI904598A7 (fi) * 1989-10-10 1991-04-11 Wrigley W M Jun Co Kuidunkehruutekniikalla valmistetut ainetta vähitellen vapauttavat rakenteet
JPH03287525A (ja) * 1990-04-03 1991-12-18 Toichi Chikuma 貼付鎮痛具
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JPH0421521U (enrdf_load_stackoverflow) * 1990-06-14 1992-02-24
US5128155A (en) * 1990-12-20 1992-07-07 Wm. Wrigley Jr. Company Flavor releasing structures for chewing gum
US5271736A (en) * 1991-05-13 1993-12-21 Applied Medical Research Collagen disruptive morphology for implants
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5819742A (en) * 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
CA2591581C (en) * 1996-12-20 2013-01-29 Alza Corporation Gel composition and methods
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
IL135061A0 (en) * 2000-03-14 2001-05-20 Ahron Jodaikin Strategic targeted fluoridation and chemical treatment of teeth
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
DE60124285T3 (de) * 2000-09-29 2011-03-17 Cordis Corp., Miami Lakes Beschichtete medizinische geräte
JP5170935B2 (ja) * 2001-11-14 2013-03-27 デュレクト コーポレーション 注入可能なデポー組成物
IL162001A0 (en) 2001-11-14 2005-11-20 Alza Corp Catheter injectable depot compositions and uses thereof
DK2561860T3 (en) * 2002-05-31 2018-04-30 Titan Pharmaceuticals Inc Implantable polymer device for prolonged release of buprenorphine
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004012703A1 (en) 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
AU2003256849A1 (en) 2002-07-31 2004-02-16 Alza Corporation Injectable multimodal polymer depot compositions and uses thereof
DE602004031512D1 (de) 2003-03-31 2011-04-07 Titan Pharmaceuticals Inc Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten
US7850453B2 (en) * 2007-08-08 2010-12-14 Coll Partners Ltd. Reshapable device for fixation at a dental site
USRE48948E1 (en) * 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
EP3415124B1 (en) * 2009-02-23 2025-04-09 Mati Therapeutics Inc. Lacrimal implants
ES2603057T3 (es) * 2009-10-30 2017-02-23 Aton Pharma, Inc. Dispositivos de administración ocular de fármacos
US8685296B2 (en) * 2010-05-11 2014-04-01 Allergan, Inc. Porogen compositions, method of making and uses
US9138308B2 (en) 2010-02-03 2015-09-22 Apollo Endosurgery, Inc. Mucosal tissue adhesion via textured surface
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9668844B2 (en) 2013-11-06 2017-06-06 Colldent Y.A Ltd Device for fixation at a dental site
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3639583A (en) * 1968-06-28 1972-02-01 Goodrich Co B F Biocidal elastomeric compositions
US3700380A (en) * 1970-10-01 1972-10-24 Tecna Corp Surface or lining compatible with blood or other tissue
GB1412983A (en) * 1971-11-30 1975-11-05 Debell & Richardson Method of producing porous plastic materials
FR2183546B1 (enrdf_load_stackoverflow) * 1972-05-10 1975-06-20 Servier Lab
JPS49118827A (enrdf_load_stackoverflow) * 1973-03-27 1974-11-13
JPS506709A (enrdf_load_stackoverflow) * 1973-05-18 1975-01-23

Also Published As

Publication number Publication date
JPS6043327B2 (ja) 1985-09-27
MX3007E (es) 1980-01-28
SE7506099L (sv) 1975-12-08
JPS5112920A (enrdf_load_stackoverflow) 1976-01-31
SE405803B (sv) 1979-01-08
DE2525061C2 (de) 1985-08-22
US3923939A (en) 1975-12-02
IT1036192B (it) 1979-10-30
DE2525061A1 (de) 1976-01-02
FR2273515B1 (enrdf_load_stackoverflow) 1980-02-15
FR2273515A1 (fr) 1976-01-02
CH611160A5 (enrdf_load_stackoverflow) 1979-05-31
CA1047403A (en) 1979-01-30

Similar Documents

Publication Publication Date Title
GB1477545A (en) Drug delivery devices
CA949292A (en) Process and apparatus for contacting a liquid with solid particles
CA945859A (en) Liquid infusion infiltration detection apparatus and method
NL162663B (nl) Werkwijze voor het polymeriseren en copolymeriseren van alkenen in aanwezigheid van een katalysator alsmede werkwijze voor het bereiden van een katalysatorelement.
NL172860C (nl) Werkwijze voor het verwijderen van vinylchloride en eventueel comonomeren uit een polymeer van vinylchloride.
FR1385374A (fr) Procédé et appareillage pour la préparation en suspension de polymères et de copolymères de type vinylique
CA942734A (en) Catalysts and process for the polymerization and copolymerization of olefins
CH507331A (fr) Procédé de préparation d'un câblé thermostable en polyester modifié destiné à être incorporé à du caoutchouc utilisable pour pneu
IL46010A (en) Hydrophobic poylmerized substrates comprising grafted hydrophilic inclusions containing polar solvent-soluble substrates and their production
NL157916B (nl) Werkwijze voor het bereiden van copolymeren van vinylverbindingen en andere mono-ethylenisch onverzadigde verbindingen.
BE769258A (fr) Dispositif pour la mise en place et l'enlevement d'elements de barrage,en particulier pour le barrage de fosses
CA963187A (en) Method and device for lake restoration by oxygen-enriching of the water
BE833040A (fr) Procede perfectionne pour nettoyer les reacteurs de polymerisation et de copolymerisation du chlorure de vinyl
CA975345A (en) Process for the polymerisation and copolymerisation of olefins
AU6602174A (en) Process and device for separating from eachother materials dissolved in water by means ofa cementation agent
YU300773A (en) Process for the polymerization and copolymerization of olefines and/or conjugated diolefines in the presence of uranium containing catalysts
BE756705A (fr) Copolymeres et terpolymeres d'ethylene contenant des esters vinyliques issus d'acides tertiaires
CA987842A (en) Uniform ethylene/vinyl acetate/n-methylol acrylamide terpolymer
FR1487845A (fr) Procédé de polymérisation de monomères vinyliques gazeux et en particulier d'alpha-oléfines
SHUTO Standing Long Waves of Finite Amplitude
CA834299A (en) Method for the saponification of polymers of ethylene, vinyl acetate and a third monomer
TONNELAT The energy aspect of the mechanism of enzyme action
CH474544A (fr) Procédé pour la copolymérisation d'esters vinyliques avec les a-oléfines
BOER The HPD-CDC 3200 system at Amsterdam(Digitizing method, software, and hardware of HPD- CDC 3200 system for analysis of bubble chamber film)
CA830018A (en) Process for the copolymerization in substance of vinyl chloride and 1,2-trans-dichloroethylene

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee